Cargando…
Change in HbA(1c) over 3 years does not improve the prediction of cardiovascular disease over and above HbA(1c) measured at a single time point
AIMS/HYPOTHESIS: HbA(1c) is an important risk factor for cardiovascular disease (CVD), with 1% higher HbA(1c) levels associated with a 10–20% increased risk of CVD. Little is known about the association between change in HbA(1c) over time and cardiovascular risk in non-diabetic populations. This stu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776254/ https://www.ncbi.nlm.nih.gov/pubmed/23404444 http://dx.doi.org/10.1007/s00125-013-2854-8 |
_version_ | 1782477461056913408 |
---|---|
author | Chamnan, P. Simmons, R. K. Khaw, K. T. Wareham, N. J. Griffin, S. J. |
author_facet | Chamnan, P. Simmons, R. K. Khaw, K. T. Wareham, N. J. Griffin, S. J. |
author_sort | Chamnan, P. |
collection | PubMed |
description | AIMS/HYPOTHESIS: HbA(1c) is an important risk factor for cardiovascular disease (CVD), with 1% higher HbA(1c) levels associated with a 10–20% increased risk of CVD. Little is known about the association between change in HbA(1c) over time and cardiovascular risk in non-diabetic populations. This study examined the association between change in HbA(1c) over time and cardiovascular risk in a non-diabetic British population. METHODS: We used data on HbA(1c) collected at baseline and at a second health examination 3 years later among a population of 5,790 non-diabetic men and women who participated in the European Prospective Investigation of Cancer (EPIC)–Norfolk. The association between change in HbA(1c) over 3 years and incident cardiovascular events over the following 8 years was examined using multivariate Cox regression. We also examined whether information on change in HbA(1c) over time improved prediction of cardiovascular events over a single measure of HbA(1c) by comparing the area under the receiver operating characteristic curves (aROC) and computing the net reclassification improvement. RESULTS: The mean change (SD) in HbA(1c) over 3 years was 0.13% (0.52). During 44,596 person-years of follow-up, 529 cardiovascular events occurred (incidence 11.9 per 1,000 person-years). Each 0.5% rise in HbA(1c) over 3 years was associated with a 9% increase in risk of a cardiovascular event (HR 1.09; 95% CI 1.01, 1.18) after adjustment for baseline HbA(1c) and other major cardiovascular risk factors. However, change in HbA(1c) was not associated with cardiovascular risk after adjustment for HbA(1c) at follow-up. Multivariate models with and without information on change in HbA(1c) over time showed a similar aROC of 0.78. Adding change in HbA(1c) to the model with HbA(1c) at follow-up did not improve risk classification. CONCLUSIONS/INTERPRETATION: Addition of information on change in HbA(1c) over 3 years did not improve the prediction of CVD over and above information on HbA(1c) and other major cardiovascular risk factors from a single time point. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-013-2854-8) contains peer-reviewed but unedited supplementary material, which is available to authorised users. |
format | Online Article Text |
id | pubmed-3776254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-37762542013-09-20 Change in HbA(1c) over 3 years does not improve the prediction of cardiovascular disease over and above HbA(1c) measured at a single time point Chamnan, P. Simmons, R. K. Khaw, K. T. Wareham, N. J. Griffin, S. J. Diabetologia Article AIMS/HYPOTHESIS: HbA(1c) is an important risk factor for cardiovascular disease (CVD), with 1% higher HbA(1c) levels associated with a 10–20% increased risk of CVD. Little is known about the association between change in HbA(1c) over time and cardiovascular risk in non-diabetic populations. This study examined the association between change in HbA(1c) over time and cardiovascular risk in a non-diabetic British population. METHODS: We used data on HbA(1c) collected at baseline and at a second health examination 3 years later among a population of 5,790 non-diabetic men and women who participated in the European Prospective Investigation of Cancer (EPIC)–Norfolk. The association between change in HbA(1c) over 3 years and incident cardiovascular events over the following 8 years was examined using multivariate Cox regression. We also examined whether information on change in HbA(1c) over time improved prediction of cardiovascular events over a single measure of HbA(1c) by comparing the area under the receiver operating characteristic curves (aROC) and computing the net reclassification improvement. RESULTS: The mean change (SD) in HbA(1c) over 3 years was 0.13% (0.52). During 44,596 person-years of follow-up, 529 cardiovascular events occurred (incidence 11.9 per 1,000 person-years). Each 0.5% rise in HbA(1c) over 3 years was associated with a 9% increase in risk of a cardiovascular event (HR 1.09; 95% CI 1.01, 1.18) after adjustment for baseline HbA(1c) and other major cardiovascular risk factors. However, change in HbA(1c) was not associated with cardiovascular risk after adjustment for HbA(1c) at follow-up. Multivariate models with and without information on change in HbA(1c) over time showed a similar aROC of 0.78. Adding change in HbA(1c) to the model with HbA(1c) at follow-up did not improve risk classification. CONCLUSIONS/INTERPRETATION: Addition of information on change in HbA(1c) over 3 years did not improve the prediction of CVD over and above information on HbA(1c) and other major cardiovascular risk factors from a single time point. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-013-2854-8) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer-Verlag 2013-02-12 2013 /pmc/articles/PMC3776254/ /pubmed/23404444 http://dx.doi.org/10.1007/s00125-013-2854-8 Text en © Springer-Verlag Berlin Heidelberg 2013 |
spellingShingle | Article Chamnan, P. Simmons, R. K. Khaw, K. T. Wareham, N. J. Griffin, S. J. Change in HbA(1c) over 3 years does not improve the prediction of cardiovascular disease over and above HbA(1c) measured at a single time point |
title | Change in HbA(1c) over 3 years does not improve the prediction of cardiovascular disease over and above HbA(1c) measured at a single time point |
title_full | Change in HbA(1c) over 3 years does not improve the prediction of cardiovascular disease over and above HbA(1c) measured at a single time point |
title_fullStr | Change in HbA(1c) over 3 years does not improve the prediction of cardiovascular disease over and above HbA(1c) measured at a single time point |
title_full_unstemmed | Change in HbA(1c) over 3 years does not improve the prediction of cardiovascular disease over and above HbA(1c) measured at a single time point |
title_short | Change in HbA(1c) over 3 years does not improve the prediction of cardiovascular disease over and above HbA(1c) measured at a single time point |
title_sort | change in hba(1c) over 3 years does not improve the prediction of cardiovascular disease over and above hba(1c) measured at a single time point |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776254/ https://www.ncbi.nlm.nih.gov/pubmed/23404444 http://dx.doi.org/10.1007/s00125-013-2854-8 |
work_keys_str_mv | AT chamnanp changeinhba1cover3yearsdoesnotimprovethepredictionofcardiovasculardiseaseoverandabovehba1cmeasuredatasingletimepoint AT simmonsrk changeinhba1cover3yearsdoesnotimprovethepredictionofcardiovasculardiseaseoverandabovehba1cmeasuredatasingletimepoint AT khawkt changeinhba1cover3yearsdoesnotimprovethepredictionofcardiovasculardiseaseoverandabovehba1cmeasuredatasingletimepoint AT warehamnj changeinhba1cover3yearsdoesnotimprovethepredictionofcardiovasculardiseaseoverandabovehba1cmeasuredatasingletimepoint AT griffinsj changeinhba1cover3yearsdoesnotimprovethepredictionofcardiovasculardiseaseoverandabovehba1cmeasuredatasingletimepoint |